USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ascensia Diabetes Care Holdings Ag

USPTO PatentsView assignee record - 227 granted patents across 49 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

227

Total patents granted

CPC technology areas

19.0

Avg claims per patent

-12%

5-year filing velocity

The verdict

Ascensia holds 227 US patents across 49 technology areas, rank #1,788 of 50,000 tracked assignees.

#1,788
of 50,000 US assignees by volume: Top 4%
by Innovation Score (59.2/100): 19.0
avg claims per patent: -12%
filing velocity, last 5 yrs

Portfolio overview

Ascensia Diabetes Care Holdings Ag has been granted 227 US utility patents between 2016 and 2025, placing Ascensia Diabetes Care Holdings Ag at rank #1,788 across all assignees tracked by PlainPatent. This portfolio spans 49 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.0 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, Ascensia Diabetes Care Holdings Ag is one of the more focused assignees in the PatentsView dataset. By volume, Ascensia sits between Tesa SE (229 patents, rank #1,784) and Exedy Corporation (227 patents, rank #1,792) - the closest US assignees by grant volume. The composite Innovation Score of 59.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 106 grants, compared with 121 in the 2015–2019 window, a -12% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Ascensia Diabetes Care Holdings Ag's 19.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 49 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ascensia Diabetes Care Holdings Ag against peers pursuing similar technology classes.

tesa SE

229
Battelle Energy A…

228
Micro Motion

228
Tachi-s

228
Axon Enterprise

227
BMIC

227
Business Objects…

227
Exedy

227
Ascensia Diabetes… ◀

227

What this shows Ascensia holds 227 patents at rank #1,788, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ascensia

By rank, the assignees closest to #1,788 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Ascensia's primary technology class.

Ascensia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

59 Top 4% higher than 96% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Ascensia Diabetes Care Holdings Ag patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	27	11.9%
2017	33	14.5%
2018	25	11.0%
2019	36	15.9%
2020	26	11.5%
2021	19	8.4%
2022	17	7.5%
2023	22	9.7%
2024	13	5.7%
2025	9	4.0%

Which technologies does Ascensia Diabetes Care Holdings Ag patent most?

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 141

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 129

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 57

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 32

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 31

G06F - ELECTRIC DIGITAL DATA PROCESSING 23

H04L - TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION 15

G01K - MEASURING TEMPERATURE; MEASURING QUANTITY OF HEAT; THERMALLY-SENSITIVE ELEMENTS NOT OTHERWISE PROVIDED FOR 10

H04M - TELEPHONIC COMMUNICATION 9

G06Q - INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR 9

H02J - CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY 8

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 8

H04W - WIRELESS COMMUNICATION NETWORKS 7

Y02D - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN INFORMATION AND COMMUNICATION TECHNOLOGIES [ICT], I.E. INFORMATION AND COMMUNICATION TECHNOLOGIES AIMING AT THE REDUCTION OF THEIR OWN ENERGY USE 7

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 6

Top 15 of 49 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#1,788

Across all tracked assignees

Innovation Score

59.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Ascensia Diabetes Care Holdings Ag hold?

Ascensia Diabetes Care Holdings Ag holds 227 US granted patents filed between 2016 and 2025, spanning 49 technology areas.

What is Ascensia Diabetes Care Holdings Ag's Innovation Score?

Ascensia Diabetes Care Holdings Ag has an Innovation Score of 59.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Ascensia Diabetes Care Holdings Ag focus on?

Ascensia Diabetes Care Holdings Ag's top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 141 patents. The company has filed patents in 49 CPC subclasses total.

Is Ascensia Diabetes Care Holdings Ag's patent filing rate increasing or decreasing?

Ascensia Diabetes Care Holdings Ag's recent filing velocity is -12% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Ascensia Diabetes Care Holdings Ag's patents?

Ascensia Diabetes Care Holdings Ag's patents average 19.0 claims each. This falls within the standard range, providing solid legal coverage.

How is the Ascensia Diabetes Care Holdings Ag patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Ascensia's 227 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Ascensia ranks #1,788 of 50,000. Top 50 holders
Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.